Generative AI’s Technology Is Not Yet Fully Optimized for Healthcare
Summary
Generative artificial intelligence (AI) faces many growing pains as it seeks its footing. In a recent survey, management consulting firm Bain & Company reveals that the main barriers to generative AI in healthcare are a lack of resources, expertise and regulation, with data access and quality and organizational resistance close behind. The recurring theme across industry studies is that generative AI in healthcare is nascent and needs time to prove its efficacy and to earn public trust. Robust benchmarks will increase confidence. The lesson for technology companies, pharmaceutical firms and healthcare providers considering generative AI in their strategies is that the technology is not yet fully optimized for healthcare. For generative AI to bear fruit, it needs investors, technology, resources, expertise, LLMs trained with healthcare-specific data, and robust guidelines. Ultimately, society needs to be ready for and comfortable with the involvement of generative AI in managing patient health and treatment. The task ahead entails expanding resources and expertise, training models on healthcare-specific data and establishing robust benchmarks. In time, through multiple iterations, generative AI will sharpen its analysis. Developers will fine-tune the benchmarks and criteria used in their models, aligning them with emerging regulatory guidelines. The result will be improved accuracy in diagnoses and recommended treatments. Ethical guidelines and human readiness will shape generative AI use and governance. Regulators are urged to move fast, but doing so too quickly could bring unintended consequences. The same caution applies to technology companies that are eager to earn a profit from their innovations. AI tools that gain FDA approval are setting a precedent for what will become commonplace in the future. The potential downside may be that ethical dilemmas will prompt companies and regulators to reconsider their positions. According to a recent study, Americans have mixed feelings about the use of generative AI in their healthcare. While they are enthusiastic about the potential benefits, most Americans are hesitant to replace their medical professionals with this technology. These sentiments may shift over time as technology matures and regulatory guidelines become more robust.The post Generative AI’s Technology Is Not Yet Fully Optimized for Healthcare first appeared on PYMNTS.com.
JPMorgan Chase has transformed money market fund shares into tokens to execute an over-the-counter derivatives trade between BlackRock and Barclays Bank u…
JPMorgan moves to commercialise blockchain with Tokenized Collateral Network
Digital Currencies
Summary
JPMorgan Chase has transformed money market fund shares into tokens to execute an over-the-counter derivatives trade between BlackRock and Barclays Bank using blockchain technology.
John Hunter, Head of Payments and Transaction Services, Wells Fargo Global Treasury Management, discusses cross-border payments at Sibos 2023, highlightin…
John Hunter, Head of Payments and Transaction Services, Wells Fargo Global Treasury Management, discusses cross-border payments at Sibos 2023, highlighting enhancements in customer experience, ongoing experimentation with new payment models, and the pivotal role of partnerships driving industry transformation.
The post Lido Dao Price Analysis: Is Lido Dao Price On The Verge Of A Major Breakthrough? appeared first on Coinpedia Fintech News The market continues to…
Lido Dao Price Analysis: Is Lido Dao Price On The Verge Of A Major Breakthrough?
Digital Currencies
Summary
The post Lido Dao Price Analysis: Is Lido Dao Price On The Verge Of A Major Breakthrough? appeared first on Coinpedia Fintech News The market continues to trade in the red as major cryptocurrencies fail to hold their price. The LDO price traded in a consolidated range of $1.456 and $1.498 for about a week. Following which the price displayed a massive price jumped from $1.456 to $1.732, a 19% rise within just two days. With this jump, the chart displayed a Golden Cross, but the price lost momentum and dipped by 10% in value. TradingView: LDO/USDT The LDO price was then seen trading in a sideways of $1.549 and $1.620 for a while following this, the coin experienced another dip in value, forming a symmetric triangle in its chart. Further, the Lido Dao coin has started moving sideways, forming a Bearish flag pattern within the triangle pattern, indicating a possibility of a negative influence over the price in the coming days. The MACD, on the other hand, displays a decline in its red histogram with a high possibility of a bullish convergence in its averages, giving us bull cycle possibility within the triangle for the LDO coin price. Also Read: Render Price Analysis: RNDR Price Signals A Bullish Move! Right Time To Buy Render Token? Will LDO Price Regain Value? In conclusion, if the bulls manage to break out of the resistance level at $1.549, then the price will gain momentum to break the bearish flag pattern. Further, if the LDO bulls hold the price above that level, it will prepare to break out the symmetric triangle at around $1.57. Moreover, if the price manages to break out, it will gain massive bullish momentum, resulting in the price testing its upper resistance of $1.664 in the coming days. On the flip side, if the market fails to gain momentum and continues to trade within the bearish flag pattern, it will lose momentum soon and test its support trendline of the triangle. If the bulls fail to hold its price at that level, then the Lido Dao price will continue to dip and test its lower support level at $1.498.
Lloyds Bank has accelerated its strategic partnership with FreedomPay, a leading consumer-centric commerce platform, as part of its continued growth strat…
Lloyds Bank has accelerated its strategic partnership with FreedomPay, a leading consumer-centric commerce platform, as part of its continued growth strategy to offer clients access to a suite of fast, efficient, and secure payments solutions.